Patients with early stage chronic lymphocytic leukemia: New risk stratification based on molecular profiling

Leukemia and Lymphoma

Volumn 52, Issue 7, 2011, Pages 1394-1397

  Antic, Darko ^a   Mihaljevic, Biljana ^a,b   Cokic, Vladan ^c   Fekete, Marija Dencic ^a   Djurasevic, Teodora Karan ^d   Pavlovic, Sonja ^d   Milic, Natasa ^b   Elezovic, Ivo ^a,b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d INSTITUTE OF MOLECULAR GENETICS AND GENETIC ENGINEERING   (Serbia)

Author keywords

Lymphoma and Hodgkin disease; molecular genetics; prognostication

Indexed keywords

BETA 2 MICROGLOBULIN; LIPOPROTEIN LIPASE; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER GROWTH; CELL INFILTRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; TIME TO FIRST TREATMENT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BETA 2-MICROGLOBULIN; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959613190     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.578311     Document Type: Article

References (10)

1. Muller-Hermelink H, Montserrat E, Catovsky D, Campo E, Harris N, Stein H. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: Swerdlow S, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoetic and lymphoid tissues. Lyon: IARC; 2008. pp 180-182.
2. Van Bockstaele F, Verhasselt B, Philippé J. Prognostic markers in chronic lymphocytic leukemia: a comprehensive review. Blood Rev 2009;23:25-47.
3. Zucchetto A, Bomben R, Dal Bo M, et al. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia. J Cell Physiol 2006;207:354-363.
4. Wierda WG, O'Brien S, Wang X, et al. Prognostic nomogram and index for overall survival in previously untreatedpatientswith chronic lymphocytic leukemia. Blood 2007;109:4679-4685. (Pubitemid 46827758)
5. Molica S, Mauro FR, Callea V, et al. The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience. Haematologica 2010;95:464-469.
6. Shanafelt TD. Predicting clinical outcome in CLL: how and why. Hematology Am Soc Hematol Educ Program 2009:421-429.
7. Shanafelt TD, Jenkins G, Call TG, et al. Validation of a new prognostic index for patients with chronic lymphocytic leukemia. Cancer 2009;115:363-372.
8. Stamatopoulos B, Meuleman N, De Bruyn C, et al. A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients. PLoS One 2010;5(9).pii:e12780.
9. Shanafelt TD, Kay NE. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Semin Oncol 2006;33:174-185.
10. Van Bockstaele F, Pede V, Janssens A, et al. Lipoprotein lipase mRNAexpression inwhole blood is a prognosticmarker inB cell chronic lymphocytic leukemia. Clin Chem 2007;53:204-212. (Pubitemid 46338264)